Press Release On Form 8-K

SECURITIES AND EXCHANGE COMMISSION

Washington D.C. 20549

 


 

FORM 8-K

 


 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (date of earliest event reported): May 24, 2005

 


 

OCTEL CORP.

(Exact name of registrant as specified in its charter)

 


 

Delaware   1-13879   98-0181725

(State or other jurisdictions

of Incorporation)

  Commission File Number  

(I.R.S. employer

identification number)

 

Octel Corp., Global House, Bailey Lane,

Manchester, UK

  M90 4AA
(Address of principal executive offices)   (zip code)

 

Registrant’s telephone number, including area code: 011 - 44 -161- 498 - 8889

 


 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 



Item 7.01 Regulation FD

 

The press release dated May 24, 2005, announced a major disruption in the market for the lead alkyl antiknock compound “TEL,” one of Octel Corp.’s products and the company’s response to the disruption. The press release is furnished as Exhibit 99.1 to this report on Form 8-K and is incorporated herein by reference.

 

Item 9.01 Financial Statements and Exhibits

 

(c) Exhibits:

 

99.1   Press Release, dated May 24, 2005, announcing a major disruption in the market for the lead alkyl antiknock compound “TEL,” one of Octel Corp.’s products, and Octel Corp.’s response to the disruption.

 

2


SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

OCTEL CORP.
By:  

/s/ Andrew Hartley


Name:   Andrew Hartley
Title:   Vice President and General Counsel

 

Date: May 24, 2005

 

3


EXHIBIT INDEX

 

Exhibit
Number  


   
99.1   Press Release, dated May 24, 2005, announcing announcing a major disruption in the market for the lead alkyl antiknock compound “TEL,” one of Octel Corp.’s products, and Octel Corp.’s response to the disruption.